4.0
Nov 27, 2023
Former employee, more than 1 year
San Francisco, CA
Recommend
CEO approval
Business outlook
Pros
Small, efficient team with great mission to provide isolation for treatment of infectious disease patients.
Cons
Startup, challenges in funding and FDA delays.